CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹37 Cr | ₹32 Cr | ₹32 Cr | ₹54 Cr | ₹77 Cr |
What is the latest Total Non-Current Liabilities ratio of CONCORD BIOTECH ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹37 Cr |
| Mar2024 | ₹32 Cr |
| Mar2023 | ₹32 Cr |
| Mar2022 | ₹54 Cr |
| Mar2021 | ₹77 Cr |
How is Total Non-Current Liabilities of CONCORD BIOTECH Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹37 Cr | 17.43 | |
| Mar2024 | ₹32 Cr | -0.71 | |
| Mar2023 | ₹32 Cr | -40.93 | |
| Mar2022 | ₹54 Cr | -29.74 | |
| Mar2021 | ₹77 Cr | - | |
Compare Total Non-Current Liabilities of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹14,095.9 Cr | 0.3% | -0.9% | -40% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,497.0 Cr | -3.5% | -5.4% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,492.0 Cr | -3.6% | 0.2% | 11.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,013.0 Cr | -0.5% | 5.9% | 20.3% | Stock Analytics | |
| CIPLA | ₹112,922.0 Cr | -1.8% | -4.8% | -1.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,115.0 Cr | -1.7% | -7.3% | -12.1% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | 0.3% |
-0.9% |
-40% |
| SENSEX | -0.7% |
-1.9% |
8% |
You may also like the below Video Courses